• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.29% Nasdaq Down3.25%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    7.26 Down 0.12(1.63%) Feb 5, 4:00PM EST
    |After Hours : 7.24 Down 0.02 (0.28%) Feb 5, 7:53PM EST
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2015Jun 30, 2015Mar 31, 2015Dec 31, 2014
    Total Revenue 1,025   2,178   486   1,477  
    Cost of Revenue -   -   -   -  
    Gross Profit 1,025   2,178   486   1,477  
    Operating Expenses
    Research Development24,656  26,490  25,125  27,026  
    Selling General and Administrative8,488  8,184  6,089  6,249  
    Non Recurring -   -   -   -  
    Others253  254  253  253  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (32,372) (32,750) (30,981) (32,051)
    Income from Continuing Operations
    Total Other Income/Expenses Net392  391  807  229  
    Earnings Before Interest And Taxes(31,980)(32,359)(30,174)(31,822)
    Interest Expense -   -   -   -  
    Income Before Tax(31,980)(32,359)(30,174)(31,822)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(31,980)(32,359)(30,174)(31,822)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (31,980) (32,359) (30,174) (31,822)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (31,980) (32,359) (30,174) (31,822)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.